Capvizr
News · All summaries
Healthcare & Life Sciences
Circle Pharma
Series E$92.5 million
RoundSeries E
Amount$92.5 million
HQSan Francisco, United States
DateSeptember 16, 2026
THE DEAL, AT A GLANCE

Circle Pharma

From the announcement
What happenedCircle Pharma raised $92.5M Series E, announced 2026-09-16From the announcement

Summarized from the deal record's source announcement; not yet independently reviewed.

Read the announcement ↗
Why it mattersCircle Pharma's $92.5M Series E is a mid-to-upper quartile capital-flow signal within the tracked FinTech funding set, ranking at the 67th percentile by round size…From the announcement

Summarized from the deal record's source announcement; not yet independently reviewed.

Read the announcement ↗
Click a part to explore its evidence. Unsupported imagery is withheld rather than guessed.Original record source ↗

Circle Pharma · Financing Record

Explore source-linked visual explanations for Circle Pharma. Unsupported claims are withheld while source review continues.

Record 12423 · Recorded date: 2026-09-16

Explore company records →
Free weekday briefing

Know which funding rounds matter before the first call.

Source-linked rounds, lead investors, and the signal behind the capital. One five-minute read.

Free · Unsubscribe anytime